Back to search

Mission Therapeutics Limited

07630933

active
Private Limited Company
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

C/O ENSORS CHARTERED ACCOUNTANTS VICTORY HOUSE, VISION PARK, CAMBRIDGE, CB24 9ZR
Incorporated 11/05/2011

Compliance

Last accounts

31/12/2025

full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 11/05/2026

Due 25/05/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Graziano Seghezzi

director · Since 24/08/2011

PARTNER SOFINNOVA PARTNERS

FRENCH,ITALIAN · FRANCE

Also on 1 other board

Dr Anker Lundemose

director · Since 09/01/2015

CHIEF EXECUTIVE OFFICER

DANISH · DENMARK

Ip2ipo Services Limited

director · Since 15/02/2018

BRITISH

Also on 143 other boards

James Summers

director · Since 01/05/2019

RETIRED

AMERICAN · UNITED STATES

Dr Jonathan Paul Hepple

director · Since 24/03/2021

VENTURE CAPITALIST

BRITISH · UNITED KINGDOM

Also on 1 other board

Iqbal Rasool Mufti

director · Since 09/07/2025

BRITISH · SWITZERLAND

Dr Anja Harmeier

director · Since 01/04/2026

SWISS,GERMAN · SWITZERLAND

Dr Marie-Claire Peakman

director · Since 24/04/2026

BRITISH,AMERICAN · UNITED STATES

Former

Mr Matthew James Foy

director · Resigned 09/07/2025

Carole Nuechterlein

director · Resigned 01/04/2026

Denis Patrick

director · Resigned 24/04/2026

CompanyRankvs 1188+ SIC 72110 peers
48

Financial strength54th percentile among SIC peers · 14/25
Employees91th percentile among SIC peers · 14/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Ccm Technologies Limited
90
10Bio - Diagnostics Limited
89
1188Mission Therapeutics Limited
58
How is this score calculated?
Financial strength14/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

future and have therefore prepared the financial statements on a going concern basis. The directors have not identified any material uncertainties that may cast significant doubt on the company's ability to continue as a going concern. Qualifying third party indemnity provision

Key FinancialsYear ending 31/12/2025

Net Worth

£1k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

—

Working capital

Current Assets

—

Current Liabilities

—

Profit After Tax

£4.7M

9avg. employees

Balance Sheet

Interest payable£1k
Prepared with CCH Software